These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 907361)

  • 21. Comparative study of the vasoconstrictor activity of halopredone acetate in a modified McKenzie test.
    Rampini E; Rastelli A; Cardo P
    Eur J Clin Pharmacol; 1978 Dec; 14(5):325-9. PubMed ID: 729625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetration of drugs through the skin.
    Stoughton RB
    Dermatologica; 1976; 152 Suppl 1():27-36. PubMed ID: 133842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacology of dermatocorticoids (2. Continuation)].
    Weirich EG
    Z Hautkr; 1978 Apr; 53(7):209-16 contd. PubMed ID: 645170
    [No Abstract]   [Full Text] [Related]  

  • 24. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of mometasone furoate on human keratinocytes and fibroblasts in vitro.
    Wach F; Bosserhoff A; Kurzidym U; Nowok K; Landthaler M; Hein R
    Skin Pharmacol Appl Skin Physiol; 1998; 11(1):43-51. PubMed ID: 9603668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
    Marks R
    Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing--skin-thickness, blood-flow and colour measurements compared to clinical assessments.
    Broby-Johansen U; Karlsmark T; Petersen LJ; Serup J
    Clin Exp Dermatol; 1990 Sep; 15(5):343-8. PubMed ID: 2225536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The decrease of hyaluronate synthesis by anti-inflammatory steroids in vitro.
    Saarni H; Hopsu-Havu VK
    Br J Dermatol; 1978 Apr; 98(4):445-9. PubMed ID: 638050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
    Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
    Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of topical corticosteroids on cell proliferation, cell cycle progression and apoptosis: in vitro comparison on HaCaT.
    Guichard A; Humbert P; Tissot M; Muret P; Courderot-Masuyer C; Viennet C
    Int J Pharm; 2015 Feb; 479(2):422-9. PubMed ID: 25556056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steroid-induced atrophy in an animal and human model.
    Kirby JD; Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():111-9. PubMed ID: 1268071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of anthralin inflammation. 2. Effect of pretreatment with glucocorticoids, anthralin and removal of stratum corneum.
    Lawrence CM; Shuster S
    Br J Dermatol; 1985 Jul; 113(1):117-22. PubMed ID: 4015968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An improved method of assessing topical corticosteroid activity.
    Barnes H; Gaylarde PM; Brock AP; Sarkany I
    Br J Dermatol; 1975 Oct; 93(4):459-64. PubMed ID: 1201192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hydrocortisone-17-butyrate, hydrocortisone, and clobetasol-17-propionate on prolyl hydroxylase activity in human skin.
    Oikarinen A; Hannuksela M
    Arch Dermatol Res; 1980; 267(1):79-82. PubMed ID: 6247982
    [No Abstract]   [Full Text] [Related]  

  • 35. Topical betamethasone-17-valerate inhibits heat-induced vasodilatation in man.
    Ahluwalia A; Flower RJ
    Br J Dermatol; 1993 Jan; 128(1):45-8. PubMed ID: 8427821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrocortisone 17-butyrate: a new topical corticosteroid preliminary report.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 12(4):249-57. PubMed ID: 786608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effect of hydrocortisone, hydrocortisone-17-butyrate and betamethasone on collagen synthesis in human skin in vivo.
    Haapasaari KM; Risteli J; Koivukangas V; Oikarinen A
    Acta Derm Venereol; 1995 Jul; 75(4):269-71. PubMed ID: 8578945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of acid mucopolysaccharide synthesis by hydrocortisone, hydrocortisone 17-butyrate and betamethasone 17-valerate.
    Saarni H; Hopsu-Havu VK
    Br J Dermatol; 1977 Nov; 97(5):505-7. PubMed ID: 145236
    [No Abstract]   [Full Text] [Related]  

  • 39. Corticosteroid-induced dermal atrophy in the rat.
    Young JM; Yoxall BE; Wagner BM
    J Invest Dermatol; 1977 Nov; 69(5):458-62. PubMed ID: 908845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chamber vasoconstrictor assay. I. Comparison with occluded and unoccluded tests using four corticosteroids.
    Somerma S
    Clin Exp Dermatol; 1980 Jun; 5(2):191-6. PubMed ID: 7438514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.